LabCorp operates one of the largest global clinical laboratory networks, managing more than 160 million patient encounters each year, or more than 3 million patient specimens per week. LabCorp also supports clinical trial activity in approximately 100 countries through its central laboratory, preclinical, and clinical development businesses. With a market cap of about $26 billion
HUM
DGX
RMD
UHS
DVA
David H. Toung
Senior Analyst: Medical Devices & Healthcare Services